drugset / Trial / NCT06949410
HER2 Vaccine for Locally Advanced Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The goal of this study is to test an investigational vaccine to activate the immune system to fight breast cancer.
Timeline
- Start
- 2026-06
- Primary completion
- 2029-12
- Completion
- 2030-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MVF HER2 597-626 | Peptide | 1.5 mg | Intramuscular |
| Subject | MVF-HER2 266-296 | Peptide | 1.5 mg | Intramuscular |